Globus Medical (GMED) Total Debt (2011 - 2024)

Globus Medical's (GMED) quarterly Total Debt came in at $443.4 million in Q4 2024, up 1.42% quarter-over-quarter from $437.1 million in Q3 2024.

Analysis

Globus Medical (GMED) Total Debt (2011 - 2024) Analysis & Trends

Globus Medical (GMED) has reported Total Debt for 5 consecutive years, with $443.4 million the latest figure, recorded in Q4 2024.

For the quarter ending Q4 2024, Total Debt changed N/A year-over-year to $443.4 million; the trailing twelve-month figure through Dec 2024 stood at $443.4 million (changed N/A YoY), and the FY2024 full-year result was $443.4 million, changed N/A from the prior year.
Total Debt advanced to $443.4 million in Q4 2024 per GMED's latest filing, from $437.1 million in the prior quarter.
Across five years, Total Debt topped out at $443.4 million in Q4 2024 and bottomed at $424.0 million in Q1 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	180.55 Bn	174.95 Bn	7.27 Bn	32.61 Bn
2	Intuitive Surgical	128.01 Bn	122.80 Bn	1.96 Bn	-
3	Medtronic	117.17 Bn	108.35 Bn	6.34 Bn	28.15 Bn
4	Stryker	104.15 Bn	100.67 Bn	4.50 Bn	14.94 Bn
5	Boston Scientific	63.37 Bn	62.83 Bn	3.85 Bn	12.62 Bn
6	Edwards Lifesciences	49.75 Bn	45.50 Bn	1.35 Bn	598.70 Mn
7	Alcon	33.01 Bn	31.55 Bn	1.68 Bn	4.15 Bn
8	Dexcom	32.16 Bn	30.22 Bn	830.00 Mn	-
9	Steris	20.74 Bn	20.25 Bn	684.20 Mn	2.14 Bn
10	Globus Medical	9.97 Bn	9.37 Bn	548.17 Mn	-

Historic Data

Download Data